Market revenue in 2023 | USD 21.3 million |
Market revenue in 2030 | USD 36.5 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 61.5% in 2023. Horizon Databook has segmented the South Korea bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
Lung cancer is the leading cause of cancer-related deaths in South Korea, with mortality rates of 53.5 per 100,000 in men and 19.0 per 100,000 in women as of 2019. The number of lung cancer deaths increased from 7,779 in 1999 to 13,698 in 2019 for males and from 2,656 to 4,876 for females during the same period.
Hence, the increasing number of cancer cases is expected to drive the demand for effective diagnostic procedures, including bronchial biopsies. Moreover, South Korea’s healthcare system is highly developed, strongly emphasizing adopting advanced technologies and providing high-quality patient care. This is expected to drive the bronchial biopsy devices market during the forecast period.
Furthermore, various initiatives are being implemented to enhance the use of bronchial biopsy devices. For instance, in 2019, South Korea launched a national lung cancer screening program utilizing low-dose Computed Tomography (CT). This initiative aims to improve early detection rates of lung cancer, which is critical for effective treatment and management.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into South Korea bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account